MediciNova Inc. (MNOV)

9.1 +0.17 (+1.904%)

IEX Real-Time Price

August 17, 2018 EST.

NASDAQ Global Market : Healthcare

Prev Close 8.93

Price Open 8.82

Volume: 74,427

Avg Volume: 86,233

Market Cap: 381.1M

P/E Ratio -47.89

52 Wk Range 4.78-14.5



MNOV Short Interest Statistics


Report Date
Float Share
Short Interest
Short Ratio
Short % to Float

2018-07-31
39.97M
2.66M
20.73
6.66%

2018-07-13
39.97M
2.93M
18.47
7.33%

2018-06-29
39.22M
3.33M
29.53
8.49%

2018-06-15
39.22M
3.28M
33.66
8.36%




MNOV Earning Report


Report Date
Fiscal Period
Announce Time
Estimated EPS(#)
Actual EPS
Surprise Dollar

2018-07-04
Q1 2018
N/A
0.00 (1)
0.00
0.00

2018-04-03
Q4 2017
N/A
-0.09 (1)
0.00
0.00

2018-03-27
Q4 2017
N/A
-0.09 (1)
0.00
0.00

2018-03-20
Q4 2017
N/A
-0.09 (1)
0.00
0.00

News

Your Daily Pharma Scoop: Array Progresses, MediciNova Trial Advances, Spark Falters (2018-08-09 02:24 SeekingAlpha)

Stocks in News: Array BioPharma combo a Breakthrough Therapy for type of colorectal cancer; shares up 8% premarket Array BioPharma ( ARRY ) announced that the combination of BRAFTOVI (encorafenib), MEKTOVI (binimetinib) and Eli Lilly's ( LLY ) ERBITUX (cetuximab) is now an FDA-designat…

 


Statistics

Shares Outstanding: 41.88M

Top 15 Institution Percent: 24.70

Price To Sales: N/A

Price To Book: 5.04

Revenue: N/A

Gross Profit: N/A

Cash: 75.42M

Debt: N/A

Return On Assets: -22.20

Return On Equity: -23.94

Profit Margin: N/A

Price History

Beta: 0.21

50-day Moving Avg: 8.88

200-day Moving Avg: 9.24

YTD Change: 37.88

5-day Change: -2.78

1-month Change: 1.34

3-month Change: -12.42

6-month Change: -17.35

1-year Change: 83.47

Revenue Per Share: 0.00

Revenue Per Employee: 0.00



Dividend

Dividend Yield: -

EX-Dividend Date: -

Dividend Rate: -


Company Profile

Name: MediciNova Inc.

Exchange: NASDAQ Global Market

Industry: Biotechnology

Sector: Healthcare

Website: http://www.medicinova.com

MediciNova Inc is a biopharmaceutical company. It is engaged in acquiring and developing small molecule therapeutics for the treatment of serious diseases with unmet medical needs.